Clinical Trials Logo

Vaccination clinical trials

View clinical trials related to Vaccination.

Filter by:

NCT ID: NCT04323137 Completed - Influenza Clinical Trials

Encouraging Flu Vaccination Among High-Risk Patients Identified by ML

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu vaccination rates of informing health-system patients who are identified by an ML analysis of EHR data to be at high risk for flu complications that they are at high risk with either (a) no additional explanation, (b) an explanation that this determination comes from an analysis of their medical records, and (c) the additional explanation that an AI or ML algorithm made this determination. 2. Evaluate the effects of the same three interventions on diagnoses of flu in the same patients.

NCT ID: NCT04096833 Completed - Pain Clinical Trials

Virtual Reality for the Treatment of Pain in Pediatric Vaccination

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Objective: to estimate the effect of virtual reality as a distracting technique against traditional distracting techniques in the vaccination procedure in the pediatric population. Design: randomized clinical trial. Field of study: the study will be carried out in the field of pediatric primary care nursing consultation, where the pediatric systematic vaccination is performed. Subjects to study: the sample will be made up of children from 3 to 14 years old who are punctured for immunization in the Fuensanta Health Center that belongs to the Department of Health Valencia-General Hospital. Variables: age, sex, family country of origin, years living in Spain, number of children of the nuclear family, order in the number of siblings, socioeconomic level, age of the caregiver that accompanies the child, affiliation / bond with the child . Group to which the subject belongs (intervention group vs. control group). Number of punctures received in the last year. Heart rate pre and post vaccination. Type of vaccine. Combination of several punctures in the query. Previous use of virtual reality. Level of pain and fear after puncture. Parent or legal guardian satisfaction. Data collection: it will be held at the Health Center on the same day as the vaccination prodecure. On the part of the nurse (heart rate, type of vaccine, combination of several punctures), the child (pain, fear) and the parents / legal guardian (satisfaction, sociodemographic). Data analysis: The descriptive analysis of the quantitative variables will be carried out through the calculation of means, typical deviations, medians, ranges, minimum and maximum values. Qualitative variables will be analyzed in absolute and relative frequencies. For the statistical inference analysis, the T-test analysis of mean difference or U-Mann Whitney (according to normal compliance) will be used. All analyzes will be performed with a 95% confidence interval.

NCT ID: NCT04054882 Completed - Vaccination Clinical Trials

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Start date: August 16, 2019
Phase: Phase 4
Study type: Interventional

Subjects will be recruited and divided into 3 groups:(1)combined immunization of Sabin-IPV and DTaP, (2) Sabin-IPV only and (3) DTaP only. After finishing the two basic vaccine EPI procedures, the immunogenicity and safety of both combined immunization group and individual vaccination groups will be compared and the data will be analyzed.

NCT ID: NCT04054492 Completed - Vaccination Clinical Trials

To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV

Start date: March 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of sequential immunization schedules of Sabin IPV and bOPV.

NCT ID: NCT04051736 Completed - Vaccination Clinical Trials

Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

Start date: March 1, 2018
Phase: Phase 4
Study type: Interventional

This study replaced the 2nd and 3rd dose of Salk-IPV (produced by Sanofi) with Sabin-IPV (produced by CNBG) and then reviewed the safety and immunogenicity of the vaccination, aiming to acquire scientific evidence for the feasibility of immunization involving different viral strains replacement.

NCT ID: NCT03956329 Completed - Infection Clinical Trials

Flu and Mood in Older Adults

For-ME
Start date: August 12, 2019
Phase: N/A
Study type: Interventional

Randomised control trial comparing the effects of a standardised and individualised positive affect digital intervention versus usual care on mood and antibody responses to influenza vaccination in older adults.

NCT ID: NCT03659773 Completed - Vaccination Clinical Trials

Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients

VaccHemInf
Start date: April 27, 2018
Phase: N/A
Study type: Interventional

Hematopoietic stem cell transplantation (HSCT) is a cellular therapy aiming at curing some hematological diseases. Upon transplantation, recipients experience a phase of profound immune suppression with loss of protective immunity against most infectious agents. Revaccination of HSCT recipients against vaccine-preventable infections is an important post-transplant intervention for reducing morbi-mortality. The VaccHemInf project aims at assessing the efficacy of recommended vaccines in adult recipients of HSCT, through the antibody titers reference method and a panel of immune functional assays.

NCT ID: NCT03599570 Completed - Vaccination Clinical Trials

The STOP-HPV Trial 2: Performance Feedback Intervention

STOP-HPV
Start date: August 7, 2018
Phase: N/A
Study type: Interventional

Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of the addition of performance feedback (period 2) to training providers previously received on HPV vaccine communication (period 1) to reduce MOs and increase HPV vaccination rates.

NCT ID: NCT03599557 Completed - Vaccination Clinical Trials

The STOP-HPV Trial 1: Communication Intervention

STOP-HPV
Start date: August 7, 2018
Phase: N/A
Study type: Interventional

Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of training providers on HPV vaccine communication to reduce MOs and increase HPV vaccination rates.

NCT ID: NCT03472014 Completed - Vaccination Clinical Trials

Special Access Program IMVAMUNE®

Start date: April 22, 2010
Phase: Phase 4
Study type: Interventional

Prophylactic smallpox vaccination for personnel actively working with or in the vicinity of replicating vaccinia virus